EAM
EFG Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.89M | Sell |
21,162
-3,529
| -14% | -$1.15M | 0.97% | 13 |
|
|
2025
Q1 | $6.67M | Sell |
24,691
-1,955
| -7% | -$528K | 1.11% | 13 |
|
|
2024
Q4 | $6.28M | Buy |
26,646
+6,031
| +29% | +$1.42M | 0.86% | 22 |
|
|
2024
Q3 | $5.67M | Buy |
20,615
+2,031
| +11% | +$559K | 0.95% | 16 |
|
|
2024
Q2 | $4.52M | Sell |
18,584
-1,362
| -7% | -$331K | 0.78% | 26 |
|
|
2024
Q1 | $2.98M | Sell |
19,946
-3,740
| -16% | -$558K | 0.51% | 64 |
|
|
2023
Q4 | $4.54M | Sell |
23,686
-4,165
| -15% | -$798K | 0.86% | 28 |
|
|
2023
Q3 | $4.93M | Sell |
27,851
-300
| -1% | -$53.1K | 1.17% | 20 |
|
|
2023
Q2 | $5.35M | Buy |
28,151
+416
| +1% | +$79.1K | 1.15% | 15 |
|
|
2023
Q1 | $5.56M | Sell |
27,735
-849
| -3% | -$170K | 1.23% | 15 |
|
|
2022
Q4 | $6.8M | Sell |
28,584
-170
| -0.6% | -$40.5K | 1.53% | 7 |
|
|
2022
Q3 | $5.75M | Buy |
28,754
+1,880
| +7% | +$376K | 1.33% | 15 |
|
|
2022
Q2 | $3.92M | Sell |
26,874
-12,321
| -31% | -$1.8M | 0.83% | 39 |
|
|
2022
Q1 | $6.4M | Buy |
+39,195
| New | +$6.4M | 0.96% | 33 |
|